Sotac Pharmaceuticals Reports Strong H1 FY27 Consolidated Results
Sotac Pharmaceuticals Ltd · Outcome · 13 Nov 2026, 11:57 pm
Sotac Pharmaceuticals Reports Strong H1 FY27 Consolidated Results Sotac Pharmaceuticals reported an 85.91% YoY increase in consolidated revenue from operations to ₹7,654.95 lakhs for the half year ended 30th Sep'26, compared to ₹4,117.61 lakhs in the previous year. Profit before tax rose 143.77% YoY to ₹817.07 lakhs from ₹335.18 lakhs. Consolidated net profit attributable to shareholders surged 117.12% YoY to ₹531.05 lakhs versus ₹244.59 lakhs in the corresponding period last year. Half-year basic and diluted EPS expanded to ₹4.81 from ₹2.21 YoY. Operating cash flow stood at ₹530.16 lakhs.
Original exchange filing (PDF)
More announcements from Sotac Pharmaceuticals Ltd
- Sotac Pharmaceuticals Limited has informed the Exchange about General Updates regarding Clarification in price movement. · 05 Nov 2026
- Significant movement in price has been observed in Sotac Pharmaceuticals Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, has written to the company. The response from the company is awaited. · 03 Nov 2026
- Sotac Pharmaceuticals Limited has informed the Exchange about Board Meeting to be held on 13-Nov-2026 to consider and approve the Half Yearly Unaudited Financial results of the Company for the period ended September 2026 and Other business. · 13 Nov 2026
- To consider and approve the financial results for the period ended September 30, 2026 and other business matters · 13 Nov 2026
- Sotac Pharmaceuticals Limited has informed the Exchange regarding the Amendment to AOA/MOA of the company. · 03 Nov 2026
- Sotac Pharmaceuticals Limited has submitted the Exchange a copy Srutinizers report of Extraordinary General Meeting held on October 31, 2026. Further, the company has informed the Exchange regarding voting results. · 02 Nov 2026
- Sotac Pharmaceuticals Limited has informed the Exchange regarding Proceedings of Extraordinary General Meeting held on October 31, 2026 · 31 Oct 2026
- Sotac Pharmaceuticals Limited has informed the Exchange regarding Notice of Extraordinary General Meeting to be held on October 31, 2026 · 08 Oct 2026
